These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35721767)

  • 1. Adverse events of Oxford/AstraZeneca's COVID-19 vaccine among health care workers of Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia.
    Tequare MH; Abraha HE; Adhana MT; Tekle TH; Belayneh EK; Gebresilassie KB; Wolderufael AL; Ebrahim MM; Tadele BA; Berhe DF; Ashebir MM; Gebrehiwot KG; Atsbaha M; Berihu BA; Desta KG; Atsbaha MT; Mengesha RE; Tsegay MA; Sibhatu MK
    IJID Reg; 2021 Dec; 1():124-129. PubMed ID: 35721767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study.
    Yesuf EA; Riad A; Sofi-Mahmudi A; Sudhakar M; Mekonnen A; Endalkachew S; Mama F; Muhidin S; Ayele B; Yahya M; Usman A; Abafita J; Klugar M
    Front Public Health; 2022; 10():937794. PubMed ID: 35928493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia.
    Darraj MA; Al-Mekhlafi HM
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia.
    Muluneh AG; Merid MW; Gelaye KA; Tilahun SY; Teshager NW; Abereha AY; Sugamo KS; Yimer MA; Kassa GM
    Infect Drug Resist; 2022; 15():2409-2416. PubMed ID: 35535029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side Effects Following Administration of the First Dose of Oxford-AstraZeneca's Covishield Vaccine in Bangladesh: A Cross-Sectional Study.
    Jahan N; Rahman FI; Saha P; Ether SA; Roknuzzaman A; Sarker R; Kalam KT; Haq K; Nyeen J; Himi HZ; Hossain MN; Chowdhury MH; Uddin MM; Alam NH
    Infect Dis Rep; 2021 Oct; 13(4):888-901. PubMed ID: 34698203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study.
    Jose D; Dhupdale N; Cacodcar JA; Kamat U
    Curr Drug Saf; 2023; 18(4):516-527. PubMed ID: 35927820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia.
    Solomon Y; Eshete T; Mekasha B; Assefa W
    J Multidiscip Healthc; 2021; 14():2577-2585. PubMed ID: 34556992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Events Following COVID-19 Vaccination in Rivers State, Nigeria: A Cross-Sectional Study.
    Harry AM; Edet CK; Ekanem NE; Kemdirim CJ; Uduak AE
    Niger Postgrad Med J; 2022; 29(2):89-95. PubMed ID: 35488575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of common adverse events experienced following COVID-19 vaccination and its associated factors in Ghana: Cross-sectional study design.
    Boi-Dsane NAA; Dzudzor B; Alhassan Y; Aheto JMK
    Health Sci Rep; 2023 Jan; 6(1):e1012. PubMed ID: 36582625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side-Effects following Oxford/AstraZeneca COVID-19 Vaccine in Tororo District, Eastern Uganda: A Cross-Sectional Study.
    Onyango J; Mukunya D; Napyo A; Nantale R; Makoko BT; Matovu JKB; Wanume B; Okia D; Okello F; Okware S; Olupot-Olupot P; Lubaale Y
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36430019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and comparison of post-vaccination adverse effects among Janssen and Oxford-AstraZeneca vaccinated adult individuals in Debre Tabor Town: A cross- sectional survey in Northwest Ethiopia.
    Chekol Abebe E; Mengie Ayele T; Tilahun Muche Z; Behaile T/Mariam A; Dagnaw Baye N; Mekonnen Agidew M; Asmamaw Dejenie T
    Hum Vaccin Immunother; 2022 Nov; 18(6):2104059. PubMed ID: 35960924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covid-19 Vaccine Side Effects and Its Associated Factors Among Healthcare Workers at Dessie Hospital, Ethiopia.
    Dewau R; Addisu E; Dessie T; Birhane T; Tadesse SE; Muche A; Feleke YW; Akele B; Yalew M; Seid KA; Damtie Y; Kefale B; Asfaw ZA; Adane B; Mebratu W; Ademas A; Cherie N; Andargie A; Genetu Chanie M; Molla A; Adane M
    J Multidiscip Healthc; 2023; 16():363-376. PubMed ID: 36785578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.
    Tobaiqy M; MacLure K; Elkout H; Stewart D
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe.
    Dziedzic A; Riad A; Attia S; Klugar M; Tanasiewicz M
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncontrolled hypertension and associated factors among adult hypertensive patients in Ayder comprehensive specialized hospital, Tigray, Ethiopia, 2018.
    Gebremichael GB; Berhe KK; Zemichael TM
    BMC Cardiovasc Disord; 2019 May; 19(1):121. PubMed ID: 31117945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of adverse events associated with 145 000 doses of COVID-19 vaccines in a Brazilian municipality.
    Martins-Filho PR; Santana RRR; Cavalcante TF; Barboza WS; de Souza MF; Góes MAO; Fontes ÂMB; da Silva MEL; Tanajura DM
    Rev Panam Salud Publica; 2022; 46():e110. PubMed ID: 36016838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
    Desalegn M; Garoma G; Tamrat H; Desta A; Prakash A
    PLoS One; 2022; 17(6):e0265140. PubMed ID: 35749520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Post-Vaccination Symptoms of Two Common COVID-19 Vaccines Used in Abha, Aseer Region, Kingdom of Saudi Arabia.
    Adam M; Gameraddin M; Alelyani M; Alshahrani MY; Gareeballah A; Ahmad I; Azzawi A; Komit B; Musa A
    Patient Prefer Adherence; 2021; 15():1963-1970. PubMed ID: 34522089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects following COVID-19 vaccination in Iran.
    Babaee E; Amirkafi A; Tehrani-Banihashemi A; SoleimanvandiAzar N; Eshrati B; Rampisheh Z; Asadi-Aliabadi M; Nojomi M
    BMC Infect Dis; 2022 May; 22(1):476. PubMed ID: 35585518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.